Computational Evaluation of Potential c-Abl Kinase Inhibitors for Parkinson’s Disease: QSAR, Docking, Bioisosteric Replacement, ADMET, and MD Simulations
2025Applied Biochemistry and BiotechnologyJournal
10.1007/s12010-025-05375-1Full text0 citations